Cargando…
Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?
BACKGROUND: This is a dosimetric comparative study intended to establish appropriate low-to-intermediate dose-constraints for the rectal wall (R(wall)) in the context of a randomized phase-II trial on urethra-sparing stereotactic body radiotherapy (SBRT) for prostate cancer. The effect of plan optim...
Autores principales: | Dubouloz, Angèle, Rouzaud, Michel, Tsvang, Lev, Verbakel, Wilko, Björkqvist, Mikko, Linthout, Nadine, Lencart, Joana, Pérez-Moreno, Juan María, Ozen, Zeynep, Escude, Lluís, Zilli, Thomas, Miralbell, Raymond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008922/ https://www.ncbi.nlm.nih.gov/pubmed/29921291 http://dx.doi.org/10.1186/s13014-018-1059-1 |
Ejemplares similares
-
Once‐a‐week or every‐other‐day urethra‐sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow‐up results
por: Zilli, Thomas, et al.
Publicado: (2020) -
State of the art and future challenges of urethra-sparing stereotactic body radiotherapy for prostate cancer: a systematic review of literature
por: Le Guevelou, Jennifer, et al.
Publicado: (2023) -
Clinical experience with lung-specific electromagnetic transponders for real-time tumor tracking in lung stereotactic body radiotherapy
por: Jaccard, Maud, et al.
Publicado: (2019) -
Salvage reirradiation for local failure of prostate cancer after curative radiation therapy: Association of rectal toxicity with dose distribution and normal-tissue complication probability models
por: Dipasquale, Giovanna, et al.
Publicado: (2018) -
Urinary toxicity after salvage re-irradiation for prostate cancer local failure after definitive radiotherapy: a clinical and dosimetric prognostic factors analysis
por: Dipasquale, Giovanna, et al.
Publicado: (2022)